Back to Search Start Over

Alternative splicing at a NAGNAG acceptor site as a novel phenotype modifier

Authors :
Alix de Becdelièvre
Catherine Costa
Agathe Tarze
Laurence Weiss
Luis J. V. Galietta
Elvira Sondo
Michel Goossens
Pascale Fanen
Natacha Martin
Christine Gameiro
Nicole Arous
Emmanuelle Girodon
Alexandre Hinzpeter
Abdel Aissat
Bruno Costes
Institut Mondor de Recherche Biomédicale (IMRB)
Institut National de la Santé et de la Recherche Médicale (INSERM)-IFR10-Université Paris-Est Créteil Val-de-Marne - Paris 12 (UPEC UP12)
Laboratorio di Genetica Molecolare
Istituto G. Gaslini
Service de Biochimie [Mondor]
Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Henri Mondor-Université Paris-Est Créteil Val-de-Marne - Paris 12 (UPEC UP12)
Service de Pédiatrie I
CHU Strasbourg-Hôpital de Hautepierre [Strasbourg]
Hinzpeter, Alexandre
Aissat, Abdel
Sondo, Elvira
Costa, Catherine
Arous, Nicole
Gameiro, Christine
Martin, Natacha
Tarze, Agathe
Weiss, Laurence
de Becdelièvre, Alix
Costes, Bruno
Goossens, Michel
Galietta, Luis J.
Girodon, Emmanuelle
Fanen, Pascale
Guellaen, Georges
Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris-Est Créteil Val-de-Marne - Paris 12 (UPEC UP12)-IFR10
Source :
PLoS Genetics, PLoS Genetics, Public Library of Science, 2010, 6 (10), pp.e1001153. ⟨10.1371/journal.pgen.1001153⟩, PLoS Genetics, Vol 6, Iss 10 (2010)
Publication Year :
2010
Publisher :
HAL CCSD, 2010.

Abstract

Approximately 30% of alleles causing genetic disorders generate premature termination codons (PTCs), which are usually associated with severe phenotypes. However, bypassing the deleterious stop codon can lead to a mild disease outcome. Splicing at NAGNAG tandem splice sites has been reported to result in insertion or deletion (indel) of three nucleotides. We identified such a mechanism as the origin of the mild to asymptomatic phenotype observed in cystic fibrosis patients homozygous for the E831X mutation (2623G>T) in the CFTR gene. Analyses performed on nasal epithelial cell mRNA detected three distinct isoforms, a considerably more complex situation than expected for a single nucleotide substitution. Structure-function studies and in silico analyses provided the first experimental evidence of an indel of a stop codon by alternative splicing at a NAGNAG acceptor site. In addition to contributing to proteome plasticity, alternative splicing at a NAGNAG tandem site can thus remove a disease-causing UAG stop codon. This molecular study reveals a naturally occurring mechanism where the effect of either modifier genes or epigenetic factors could be suspected. This finding is of importance for genetic counseling as well as for deciding appropriate therapeutic strategies.<br />Author Summary Mild disease outcomes associated with premature termination codons can result from at least three different mechanisms, but none of these mechanisms explain the mild phenotype observed in some patients. Subtle differences in alternative transcripts have recently been reported at NAGNAG tandem acceptor motifs, which can be detected in 30% of human genes. We provide the first experimental evidence of premature termination codon removal by alternative splicing at a NAGNAG acceptor splice site. Our study emphasizes the biological significance of such alternative splicing in the context of disease-causing mutations and defines a new phenotype-modifying mechanism that buffers nonsense mutations.

Details

Language :
English
ISSN :
15537390 and 15537404
Database :
OpenAIRE
Journal :
PLoS Genetics, PLoS Genetics, Public Library of Science, 2010, 6 (10), pp.e1001153. ⟨10.1371/journal.pgen.1001153⟩, PLoS Genetics, Vol 6, Iss 10 (2010)
Accession number :
edsair.doi.dedup.....737fbc78e97c33bee0a3aa2838bf9298
Full Text :
https://doi.org/10.1371/journal.pgen.1001153⟩